Shuttle Pharmaceuticals (SHPH) Competitors $0.13 -0.01 (-9.35%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$0.13 0.00 (-1.36%) As of 06/13/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SHPH vs. APLM, GTBP, MYNZ, SBFM, CHRO, OMGA, IMCC, KTTA, ALBT, and AIMShould you be buying Shuttle Pharmaceuticals stock or one of its competitors? The main competitors of Shuttle Pharmaceuticals include Apollomics (APLM), GT Biopharma (GTBP), Mainz Biomed (MYNZ), Sunshine Biopharma (SBFM), Chromocell Therapeutics (CHRO), Omega Therapeutics (OMGA), IM Cannabis (IMCC), Pasithea Therapeutics (KTTA), Avalon GloboCare (ALBT), and AIM ImmunoTech (AIM). These companies are all part of the "pharmaceutical products" industry. Shuttle Pharmaceuticals vs. Its Competitors Apollomics GT Biopharma Mainz Biomed Sunshine Biopharma Chromocell Therapeutics Omega Therapeutics IM Cannabis Pasithea Therapeutics Avalon GloboCare AIM ImmunoTech Apollomics (NASDAQ:APLM) and Shuttle Pharmaceuticals (NASDAQ:SHPH) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, risk, dividends, earnings, analyst recommendations, institutional ownership, community ranking and media sentiment. Does the media favor APLM or SHPH? In the previous week, Shuttle Pharmaceuticals had 7 more articles in the media than Apollomics. MarketBeat recorded 8 mentions for Shuttle Pharmaceuticals and 1 mentions for Apollomics. Apollomics' average media sentiment score of 1.87 beat Shuttle Pharmaceuticals' score of 0.48 indicating that Apollomics is being referred to more favorably in the media. Company Overall Sentiment Apollomics Very Positive Shuttle Pharmaceuticals Neutral Does the MarketBeat Community favor APLM or SHPH? Apollomics received 4 more outperform votes than Shuttle Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformApollomicsOutperform Votes480.00% Underperform Votes120.00% Shuttle PharmaceuticalsN/AN/A Which has more risk & volatility, APLM or SHPH? Apollomics has a beta of 0.9, indicating that its share price is 10% less volatile than the S&P 500. Comparatively, Shuttle Pharmaceuticals has a beta of -1.1, indicating that its share price is 210% less volatile than the S&P 500. Do institutionals and insiders hold more shares of APLM or SHPH? 19.1% of Apollomics shares are held by institutional investors. Comparatively, 4.6% of Shuttle Pharmaceuticals shares are held by institutional investors. 12.6% of Shuttle Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has stronger valuation and earnings, APLM or SHPH? Shuttle Pharmaceuticals has lower revenue, but higher earnings than Apollomics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioApollomics$1.22M5.82-$172.60MN/AN/AShuttle PharmaceuticalsN/AN/A-$6.59M-$4.15-0.03 Is APLM or SHPH more profitable? Apollomics' return on equity of 0.00% beat Shuttle Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets ApollomicsN/A N/A N/A Shuttle Pharmaceuticals N/A -583.02%-258.92% SummaryApollomics beats Shuttle Pharmaceuticals on 7 of the 10 factors compared between the two stocks. Get Shuttle Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SHPH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SHPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SHPH vs. The Competition Export to ExcelMetricShuttle PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.46M$6.88B$5.57B$8.51BDividend YieldN/A2.49%5.27%4.16%P/E Ratio-0.038.4626.7519.65Price / SalesN/A262.48404.17152.19Price / CashN/A65.8538.2534.64Price / Book0.076.526.964.59Net Income-$6.59M$143.26M$3.23B$248.23M7 Day Performance-97.10%-0.21%-1.23%-1.07%1 Month Performance-97.61%10.62%6.34%2.59%1 Year PerformanceN/A3.63%33.04%13.50% Shuttle Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SHPHShuttle Pharmaceuticals0.7872 of 5 stars$0.13-9.4%N/AN/A$1.46MN/A-0.035News CoverageStock SplitShort Interest ↓High Trading VolumeAPLMApollomics1.2333 of 5 stars$6.55flatN/A-68.0%$7.23M$1.22M0.0045Negative NewsGap DownGTBPGT Biopharma2.6502 of 5 stars$2.79+3.0%$11.00+294.3%-1.7%$7.22MN/A-0.498Short Interest ↑Gap UpMYNZMainz Biomed2.6045 of 5 stars$2.05+0.2%$14.00+584.6%-92.7%$7.02M$893.99K-0.0330Gap UpSBFMSunshine Biopharma2.8454 of 5 stars$1.52+7.2%$15.00+885.5%+369.7%$6.95M$36.23M-0.013Positive NewsGap UpCHROChromocell Therapeutics1.1631 of 5 stars$1.05+2.9%N/A-5.7%$6.93MN/A-0.854Short Interest ↓OMGAOmega Therapeutics1.9684 of 5 stars$0.13-21.8%$9.20+7,260.0%-93.8%$6.92M$8.10M-0.09120Upcoming EarningsGap UpIMCCIM Cannabis0.404 of 5 stars$3.05-12.4%N/A-11.7%$6.81M$54.47M-0.89340Short Interest ↑Gap DownHigh Trading VolumeKTTAPasithea Therapeutics1.5668 of 5 stars$0.91-2.5%N/A-85.1%$6.75MN/A-0.093Short Interest ↓Gap DownALBTAvalon GloboCare2.2225 of 5 stars$3.55-2.5%N/A-53.4%$6.72M$1.37M-0.185Short Interest ↓AIMAIM ImmunoTech1.6464 of 5 stars$0.09-22.3%$2.75+2,908.8%-79.6%$6.61M$170K-0.1920News CoverageGap DownHigh Trading Volume Related Companies and Tools Related Companies APLM Alternatives GTBP Alternatives MYNZ Alternatives SBFM Alternatives CHRO Alternatives OMGA Alternatives IMCC Alternatives KTTA Alternatives ALBT Alternatives AIM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SHPH) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shuttle Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shuttle Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
